Target-based agents in neoadjuvant treatment of liver metastases from colorectal cancer

Secret weapons in anti-cancer war?

Monica Marra, Aldo Giudice, Claudio Arra, Giovanni Vitale, Sara Castiglioni, Guglielmo Nasti, Angela Lombardi, Alessandro Ottaiano, Gaetano Facchini, Rosario V. Iaffaioli, Alberto Abbruzzese, Michele Caraglia

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The therapeutic options for liver metastases of colorectal cancer mainly include surgical resection and palliative chemotherapy. More recently, the increased availability of new and more active cytotoxic drugs has increased the appeal of a combined treatment strategy, in which chemotherapy is administered before surgery. However, the efficacy of neoadjuvant chemotherapy of CRC liver metastases is limited by: (1) the persistence of micro metastatic foci that cannot be seen by conventional imaging techniques, placed either in other sites throughout the liver and/or in the site of the previous macroscopic metastasis that has undergone to clinical complete response; (2) the occurrence of escape mechanisms. The molecular basis regulating these processes are described and the first clinical attempts to overcome these mechanisms through the use of target-based agents are also reported. Finally, biological rationales to optimize the activity of these agents in neoadjuvant setting are discussed.

Original languageEnglish
Pages (from-to)1709-1718
Number of pages10
JournalCancer Biology and Therapy
Volume8
Issue number18
Publication statusPublished - Sep 15 2009

Fingerprint

Neoadjuvant Therapy
Weapons
Colorectal Neoplasms
Neoplasm Metastasis
Drug Therapy
Liver
Neoplasms
Therapeutics
Pharmaceutical Preparations
Warfare

Keywords

  • Angiogenesis
  • Colorectal cancer
  • Liver metastases
  • Neoadjuvant therapy
  • Target-based agents

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this

Target-based agents in neoadjuvant treatment of liver metastases from colorectal cancer : Secret weapons in anti-cancer war? / Marra, Monica; Giudice, Aldo; Arra, Claudio; Vitale, Giovanni; Castiglioni, Sara; Nasti, Guglielmo; Lombardi, Angela; Ottaiano, Alessandro; Facchini, Gaetano; Iaffaioli, Rosario V.; Abbruzzese, Alberto; Caraglia, Michele.

In: Cancer Biology and Therapy, Vol. 8, No. 18, 15.09.2009, p. 1709-1718.

Research output: Contribution to journalArticle

@article{2253590b717945b8939e0dea7392ef4c,
title = "Target-based agents in neoadjuvant treatment of liver metastases from colorectal cancer: Secret weapons in anti-cancer war?",
abstract = "The therapeutic options for liver metastases of colorectal cancer mainly include surgical resection and palliative chemotherapy. More recently, the increased availability of new and more active cytotoxic drugs has increased the appeal of a combined treatment strategy, in which chemotherapy is administered before surgery. However, the efficacy of neoadjuvant chemotherapy of CRC liver metastases is limited by: (1) the persistence of micro metastatic foci that cannot be seen by conventional imaging techniques, placed either in other sites throughout the liver and/or in the site of the previous macroscopic metastasis that has undergone to clinical complete response; (2) the occurrence of escape mechanisms. The molecular basis regulating these processes are described and the first clinical attempts to overcome these mechanisms through the use of target-based agents are also reported. Finally, biological rationales to optimize the activity of these agents in neoadjuvant setting are discussed.",
keywords = "Angiogenesis, Colorectal cancer, Liver metastases, Neoadjuvant therapy, Target-based agents",
author = "Monica Marra and Aldo Giudice and Claudio Arra and Giovanni Vitale and Sara Castiglioni and Guglielmo Nasti and Angela Lombardi and Alessandro Ottaiano and Gaetano Facchini and Iaffaioli, {Rosario V.} and Alberto Abbruzzese and Michele Caraglia",
year = "2009",
month = "9",
day = "15",
language = "English",
volume = "8",
pages = "1709--1718",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "18",

}

TY - JOUR

T1 - Target-based agents in neoadjuvant treatment of liver metastases from colorectal cancer

T2 - Secret weapons in anti-cancer war?

AU - Marra, Monica

AU - Giudice, Aldo

AU - Arra, Claudio

AU - Vitale, Giovanni

AU - Castiglioni, Sara

AU - Nasti, Guglielmo

AU - Lombardi, Angela

AU - Ottaiano, Alessandro

AU - Facchini, Gaetano

AU - Iaffaioli, Rosario V.

AU - Abbruzzese, Alberto

AU - Caraglia, Michele

PY - 2009/9/15

Y1 - 2009/9/15

N2 - The therapeutic options for liver metastases of colorectal cancer mainly include surgical resection and palliative chemotherapy. More recently, the increased availability of new and more active cytotoxic drugs has increased the appeal of a combined treatment strategy, in which chemotherapy is administered before surgery. However, the efficacy of neoadjuvant chemotherapy of CRC liver metastases is limited by: (1) the persistence of micro metastatic foci that cannot be seen by conventional imaging techniques, placed either in other sites throughout the liver and/or in the site of the previous macroscopic metastasis that has undergone to clinical complete response; (2) the occurrence of escape mechanisms. The molecular basis regulating these processes are described and the first clinical attempts to overcome these mechanisms through the use of target-based agents are also reported. Finally, biological rationales to optimize the activity of these agents in neoadjuvant setting are discussed.

AB - The therapeutic options for liver metastases of colorectal cancer mainly include surgical resection and palliative chemotherapy. More recently, the increased availability of new and more active cytotoxic drugs has increased the appeal of a combined treatment strategy, in which chemotherapy is administered before surgery. However, the efficacy of neoadjuvant chemotherapy of CRC liver metastases is limited by: (1) the persistence of micro metastatic foci that cannot be seen by conventional imaging techniques, placed either in other sites throughout the liver and/or in the site of the previous macroscopic metastasis that has undergone to clinical complete response; (2) the occurrence of escape mechanisms. The molecular basis regulating these processes are described and the first clinical attempts to overcome these mechanisms through the use of target-based agents are also reported. Finally, biological rationales to optimize the activity of these agents in neoadjuvant setting are discussed.

KW - Angiogenesis

KW - Colorectal cancer

KW - Liver metastases

KW - Neoadjuvant therapy

KW - Target-based agents

UR - http://www.scopus.com/inward/record.url?scp=73249147914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73249147914&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 1709

EP - 1718

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 18

ER -